scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1743-6109.2009.01667.X |
P698 | PubMed publication ID | 20102444 |
P2093 | author name string | Chitra Raghunandan | |
Monisha Choudhury | |||
Swati Agrawal | |||
Priyanka Dubey | |||
Anju Jain | |||
P433 | issue | 3 | |
P921 | main subject | testosterone | Q27863114 |
estrogen | Q277954 | ||
sexual dysfunction | Q1137463 | ||
testosterone | Q1318776 | ||
P1104 | number of pages | 7 | |
P304 | page(s) | 1284-1290 | |
P577 | publication date | 2010-01-19 | |
P1433 | published in | The Journal of Sexual Medicine | Q7743627 |
P1476 | title | A comparative study of the effects of local estrogen with or without local testosterone on vulvovaginal and sexual dysfunction in postmenopausal women | |
P478 | volume | 7 |
Q33605919 | A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy |
Q30594492 | An observational outcomes study from 1966-2008, examining pregnancy and neonatal outcomes from dialysed women using data from the ANZDATA Registry |
Q38232359 | Assessment of vaginal atrophy: a review |
Q37567415 | Comparison between vaginal royal jelly and vaginal estrogen effects on quality of life and vaginal atrophy in postmenopausal women: a clinical trial study |
Q37102836 | Comparison of the Effects of Vaginal Royal Jelly and Vaginal Estrogen on Quality of Life, Sexual and Urinary Function in Postmenopausal Women |
Q26783453 | Local Oestrogen for Pelvic Floor Disorders: A Systematic Review |
Q38941662 | Local oestrogen for vaginal atrophy in postmenopausal women. |
Q37218064 | Ospemifene May Not Treat Vulvar Atrophy: A Report of Two Cases |
Q85048234 | Sexual Dysfunction in CKD |
Q47650581 | Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. |
Q35735025 | Survivorship: sexual dysfunction (female), version 1.2013. |
Q38584377 | Testosterone in women--the clinical significance |
Q47823176 | The concomitant use of fesoterodine and topical vaginal estrogen in the management of overactive bladder and sexual dysfunction in postmenopausal women. |
Q35584556 | Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study. |
Q34150819 | Vaginal Estrogens for the Treatment of Dyspareunia |
Q36865142 | Vaginal estrogen for genitourinary syndrome of menopause: a systematic review. |
Search more.